Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior hypogastric nerve block for pain control after uterine artery embolisation
ACTRN12614001253695Phase 2Not yet recruiting
- Sponsor
- Professor Ken Thomson
- Start
- Dec 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine, epinephrine and sodium chloride in Fibromyoma (LM) (2 arms), sponsored by Professor Ken Thomson. Primary endpoints: Mean postoperative pain intensity and Time to suitability for discharge. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
bupivacaineepinephrinesodium chloride
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on ACTRN12614001253695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001253695.